AssetMark Inc’s SOPHiA GENETICS SOPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$51K Buy
8,836
+4,125
+88% +$20.9K ﹤0.01% 1828
2026
Q1
$23.3K Buy
4,711
+24
+0.5% +$117 ﹤0.01% 1997
2025
Q4
$21.9K Buy
4,687
+566
+14% +$2.56K ﹤0.01% 1975
2025
Q3
$19.6K Buy
4,121
+2,307
+127% +$7.93K ﹤0.01% 1925
2025
Q2
$5.62K Buy
1,814
+43
+2% +$128 ﹤0.01% 2102
2025
Q1
$5.88K Sell
1,771
-169
-9% -$594 ﹤0.01% 1957
2024
Q4
$5.96K Sell
1,940
-329
-14% -$1.12K ﹤0.01% 1890
2024
Q3
$8.28K Buy
2,269
+337
+17% +$1.37K ﹤0.01% 1649
2024
Q2
$8.85K Buy
1,932
+51
+3% +$249 ﹤0.01% 1520
2024
Q1
$9.27K Sell
1,881
-259
-12% -$1.25K ﹤0.01% 1389
2023
Q4
$10.1K Buy
2,140
+306
+17% +$1.14K ﹤0.01% 1380
2023
Q3
$4.67K Buy
1,834
+285
+18% +$904 ﹤0.01% 1399
2023
Q2
$6.94K Buy
1,549
+572
+59% +$2.59K ﹤0.01% 1320
2023
Q1
$4.86K Buy
977
+397
+68% +$1.28K ﹤0.01% 1328
2022
Q4
$1.2K Sell
580
-144
-20% -$323 ﹤0.01% 1473
2022
Q3
$2K Buy
724
+301
+71% +$1.05K ﹤0.01% 1409
2022
Q2
$2K Buy
423
+213
+101% +$1.08K ﹤0.01% 1392
2022
Q1
$2K Buy
+210
New +$2.36K ﹤0.01% 1442

Other funds holding SOPH

AssetMark Inc's SOPH Position: Q2 2026 in Review

AssetMark Inc increased its SOPHiA GENETICS (SOPH) stake by 88% in Q2 2026, buying an estimated $20.9K and bringing the position to 8,836 shares worth $51K. The position accounts for ﹤0.01% of the portfolio, ranked #1828.

AssetMark Inc first reported a position in SOPH in Q1 2022 and has held it in 18 quarters since. 16 funds tracked by Wall St. Rank hold SOPH as of Q2 2026.

  • AssetMark Inc held 8,836 shares of SOPHiA GENETICS worth $51K as of Q2 2026.
  • AssetMark Inc bought 4,125 SOPHiA GENETICS shares in Q2 2026, an estimated $20.9K.
  • SOPHiA GENETICS made up ﹤0.01% of AssetMark Inc's portfolio in Q2 2026, its #1828 holding.
  • AssetMark Inc first reported a position in SOPHiA GENETICS in Q1 2022 and has held it in 18 quarters since.
  • 16 funds tracked by Wall St. Rank held SOPHiA GENETICS as of Q2 2026.

Based on AssetMark Inc's 13F filing for Q2 2026, filed 30 Jul 2026.